Multicancer early detection tests are revolutionizing cancer screening by using liquid biopsies to screen for multiple ...

Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

Scientists at the Liverpool School of Tropical Medicine (LSTM) have developed a more precise diagnostic tool to distinguish ...

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

Phase 2 evaluation of the nilotinib-paclitaxel combination in patients with rare solid tumors: Rapid analysis and response evaluation of combination anti-neoplastic agents in rare tumors trial 1 (RARE ...

Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

DNA methylation, RTK pathway changes, and KRAS amplifications may drive resistance to sotorasib plus panitumumab in KRAS G12C ...

The smartphone-sized, battery-powered test is a cost-effective tool that can improve TB diagnoses, particularly in rural areas where facilities and equipment are less accessible. Dr. Tony Hu, a Tulane ...

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has been ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...